Press Releases
🇪🇺 EMA Page 9EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Access critical pharma & biotech press releases. Stay ahead on drug approvals, clinical trials, M&A, and regulatory updates impacting global markets.
Showing 97–108 of 121 articles
AskBio's Ametefgene Parvec Enters Phase II Trial for Parkinson's Disease Gene Therapy
Adagene's Muzastotug Shows 66.7% Response Rate in Triple Combination Therapy for Hepatocellular Carcinoma at AACR 2026
HYTN Innovations Launches HARd Cannabis Remediation Technology for GMP Processing Services in Germany
Sanofi's Nuvaxovid COVID-19 Vaccine Shows Superior Tolerability Over mNEXSPIKE in Phase 4 Study
Brand Institute Receives First EMA Approval for AI-Developed Pharmaceutical Brand Name Using Brandi Platform
Gene Therapy Market to Reach $43.8 Billion by 2034 as CRISPR and AAV Technologies Drive 12.27% Annual Growth
Healthcare Cold Chain Logistics Market to Surge Through 2034 as Biopharmaceutical Demand Drives Asia-Pacific Growth
AIM ImmunoTech Advances Ampligen to Phase 3 Pancreatic Cancer Trial with Orphan Drug Status
AB Science Secures €25 Million Clinical Trial Insurance for Masitinib ALS Phase III Study
MeiraGTx Acquires Botaretigene Sparoparvovec Gene Therapy from Johnson & Johnson for X-linked Retinitis Pigmentosa Treatment
Traws Pharma Advances Tivoxavir Marboxil to Human Influenza Challenge Trial, Reports Positive Ratutrelvir COVID Data
New Additional Risk Minimization Measures (aRMMs) Training Course Launches to Enhance Pharmaceutical Patient Safety Protocols